ALK and mature T-cell and NK-cell non-Hodgkin lymphoma: When compared with their B-cell NHL counterparts, most PTCL histologies, with the exception of ALK-positive ALCL, are more difficult to treat and are associated with worse progression-free survival (PFS) and overall survival (OS; Skarbnik et al., 2013).